Dying Patient Calls for Personalized Medicine

Adriana Jenkins, a public relations specialist for numerous biotech companies, has died from breast cancer. Jenkins was diagnosed with an aggressive form of breast cancer when she was just 31. Before she died, Jenkins wrote an editorial in Forbes calling for pharma to embrace personalized medicine.

Her doctors discovered that she had HER2-positive breast cancer, which accounts for about 25 percent of all breast cancer cases. And at that time Genentech was enrolling patients in